Skip to main content

PHASE 3 STUDY EVALUATING GENE THERAPY BY TRANSPLANTATION OF AUTOLOGOUS CD34+ STEM CELLS TRANSDUCED EX VIVO WITH THE LENTIGLOBIN BB305 LENTIVIRAL VECTOR IN SUBJECTS WITH SEVERE SICKLE CELL DISEASE

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Transplant and Cellular Therapy

Awarded By

Bluebird Bio

Start Date

April 17, 2020

End Date

March 29, 2023
 

Administered By

Pediatrics, Transplant and Cellular Therapy

Awarded By

Bluebird Bio

Start Date

April 17, 2020

End Date

March 29, 2023